Work

A 96‐week, multinational, randomized, double‐blind, parallel‐group, clinical trial evaluating the safety and effectiveness of bexagliflozin as a monotherapy for adults with type 2 diabetes

Year: 2019

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Diabetes Obesity and Metabolism

DOI: 10.1111/dom.13833

Authors: Yuan‐Di C. Halvorsen, Geoffrey A. Walford, Joseph Massaro, Robert P. Aftring, Mason W. Freeman

Institutions: Massachusetts General Hospital, Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston University, Theracos (United States)

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: World Health Organization, Massachusetts General Hospital

OpenAlex ID: W2956311553

FWCI: 2.435

Cites: 26

Cited by: 46

Related to: 10